Skip to content
Application 203323
- Type
- ANDA
- Sponsor
- SAGENT PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AMIKACIN SULFATE | AMIKACIN SULFATE | INJECTABLE;INJECTION | EQ 250MG BASE/ML | No | No |
| 002 | AMIKACIN SULFATE | AMIKACIN SULFATE | INJECTABLE;INJECTION | 500MG(BASE)/ML(250MG/ML) | Yes | No |
| 003 | AMIKACIN SULFATE | AMIKACIN SULFATE | INJECTABLE;INJECTION | 1G(BASE)/4ML(250MG/ML) | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 25021-173 | amikacin sulfate | amikacin sulfate | Sagent Pharmaceuticals | ANDA | Current |
| 25021-173 | amikacin sulfate | amikacin sulfate | Sagent Pharmaceuticals | ANDA | Current |
| 25021-173 | amikacin sulfate | amikacin sulfate | Sagent Pharmaceuticals | ANDA | Current |